LEADER 02165nam 22005774a 450 001 9910456194003321 005 20200520144314.0 010 $a0-309-66156-0 035 $a(CKB)111069351121074 035 $a(SSID)ssj0000387898 035 $a(PQKBManifestationID)11272444 035 $a(PQKBTitleCode)TC0000387898 035 $a(PQKBWorkID)10411390 035 $a(PQKB)11228312 035 $a(MiAaPQ)EBC3378094 035 $a(Au-PeEL)EBL3378094 035 $a(CaPaEBR)ebr10126244 035 $a(OCoLC)817958315 035 $a(EXLCZ)99111069351121074 100 $a20011011d2002 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aCommunity programs to promote youth development$b[electronic resource] /$fCommittee on Community-Level Programs for Youth, Jacquelynne Eccles and Jennifer Appleton Gootman, editors 210 $aWashington, DC $cNational Academy Press$dc2002 215 $axvii, 411 p. $cill 300 $a"Board on Children, Youth, and Families, Division of Behavioral and Social Sciences and Education, National Research Council and Institute of Medicine." 300 $a"Division of Behavioral and Social Sciences and Education."--t.p. 311 $a0-309-10590-0 311 $a0-309-07275-1 320 $aIncludes bibliographical references (p. 342-391) and index. 606 $aYouth$xServices for$zUnited States 606 $aTeenagers$xServices for$zUnited States 608 $aElectronic books. 615 0$aYouth$xServices for 615 0$aTeenagers$xServices for 676 $a362.7/083 701 $aEccles$b Jacquelynne S$0948931 701 $aGootman$b Jennifer Appleton$0956594 712 02$aNational Research Council (U.S.).$bCommittee on Community-Level Programs for Youth. 712 02$aNational Research Council (U.S.).$bBoard on Children, Youth, and Families. 712 02$aInstitute of Medicine (U.S.) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910456194003321 996 $aCommunity programs to promote youth development$92264276 997 $aUNINA LEADER 05371nam 2200757Ia 450 001 9910139455003321 005 20200520144314.0 010 $a9786613098672 010 $a9781283098670 010 $a1283098679 010 $a9781118015803 010 $a1118015800 010 $a9781118015810 010 $a1118015819 010 $a9781118015797 010 $a1118015797 035 $a(CKB)2550000000032301 035 $a(EBL)697492 035 $a(OCoLC)729730591 035 $a(SSID)ssj0000506244 035 $a(PQKBManifestationID)11320721 035 $a(PQKBTitleCode)TC0000506244 035 $a(PQKBWorkID)10513357 035 $a(PQKB)10040638 035 $a(MiAaPQ)EBC697492 035 $a(Au-PeEL)EBL697492 035 $a(CaPaEBR)ebr10466737 035 $a(CaONFJC)MIL309867 035 $a(PPN)242450040 035 $a(Perlego)1014255 035 $a(EXLCZ)992550000000032301 100 $a20101022h20112011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aBiodegradable polymers in clinical use and clinical development /$fedited by Abraham J. Domb, Neeraj Kumar, and Aviva Ezra 205 $a1st ed. 210 $aHoboken, NJ $cWiley$d2011 215 $a1 online resource (752 p.) 300 $aDescription based upon print version of record. 311 08$a9780470424759 311 08$a0470424753 320 $aIncludes bibliographical references and index. 327 $aBiodegradable Polymers in Clinical Use and Clinical Development; Contents; Contributors; Preface; Part I: General; 1: Biodegradable Polymers in Drug Delivery: Jay Prakash Jain, Wubante Yenet, Abraham J. Domb, and Neeraj Kumar; Part II: Biodegradable Polymers of Natural Origin: Protein-Based Polymers; 2: Collagen: Wahid Khan, Deepak Yadav, Abraham J. Domb, and Neeraj Kumar; 3: Properties and Hemostatic Application of Gelatin: Jalindar Totre, Diana Ickowicz, and Abraham J. Domb; Part III: Biodegradable Polymers of Natural Origin: Polysaccharides 327 $a4: Chitosan and Its Derivatives in Clinical Use and Applications: Anuradha Subramanian, Kirthanashri Srinivasan Vasanthan,Uma Maheswari Krishnan, and Swaminathan Sethuraman5: Clinical Uses of Alginate: Udi Nussinovitch and Amos Nussinovitch; 6: Dextran and Pentosan Sulfate - Clinical Applications: Ramu Parthasarathi and Athipettah Jayakrishnan; 7: Arabinogalactan in Clinical Use: Rajendra P. Pawar, Babasaheb A. Kushekar, Bhaskar S. Jadhav, Kiran R. Kharat, Ravikumar M. Borade, and Abraham J. Domb; Part IV: Biodegradable Polymers of Natural Origin: Polyesters 327 $a8: Polyhydroxyalkanoate: Kesaven Bhubalan, Wing-Hin Lee, and Kumar SudeshPart V: Synthetic Biodegradable Polymers; 9: Lactide and Glycolide Polymers: Kevin Letchford, Anders So?dergard, David Plackett, Samuel Gilchrist, and Helen Burt; 10: Polyanhydrides-Poly(CPP-SA), Fatty-Acid-Based Polyanhydrides: Ravikumar M. Borade, Abraham J. Domb, Archana A. Sawale, Rajendra P. Pawar, and Kiran R. Kharat; 11: Poly(&03B5; -Caprolactone-co-Glycolide): Biomedical Applications of a Unique Elastomer: Kevin Cooper, Aruna Nathan, and Murty Vyakarnam 327 $a12: Medicinal Applications of Cyanoacrylate: Rajendra P. Pawar, Ashok E. Jadhav, Sumangala B. Tathe, Bhimrao C. Khade, and Abraham J. Domb13: Polyethylene Glycol in Clinical Application and PEGylated Drugs: Teerapol Srichana, and Tan Suwandecha; Part VI: Inorganic Polymers; 14: Calcium-Phosphate-Based Ceramics for Biomedical Applications: Qing Lv, Kevin W.-H. Lo, Lakshmi S. Nair, and Cato T. Laurencin; Part VII: Biodegradable Polymers for Emerging Clinical Uses; 15: Biocompatible Polymers for Nucleic Acid Delivery: Jeff Sparks, and Khursheed Anwer 327 $a16: Biodegradable Polymers for Emerging Clinical Use in Tissue Engineering: Shalini Verma, Kalpna Garkhal, Anupama Mittal, and Neeraj Kumar17: Injectable Polymers: Shimon A. Unterman, Norman A. Marcus, and Jennifer H. Elisseeff; Part VIII: IPR Aspects of Biodegradable Polymers; 18: Global Patent and Technological Status of Biodegradable Polymers in Drug Delivery and Tissue Engineering: Parikshit Bansal, Shalini Verma, Wahid Khan, and Neeraj Kumar; Index 330 $aThis book focuses on biodegradable polymers that are already in clinical use or under clinical development. Synthetic and natural polymers will be included. This excludes polymers that have been investigated and did not reach clinical development. The purpose of this book is to provide updated status of the polymers that are clinical use and those that are now being developed for clinical use and hopefully will reach the clinic during the next 5 years. The book provides information that of interest to academics and practicing researchers including chemists, biologists and bioengineers an 606 $aPolymers in medicine 606 $aBiodegradable plastics 615 0$aPolymers in medicine. 615 0$aBiodegradable plastics. 676 $a610.28/4 686 $aTEC009010$2bisacsh 701 $aDomb$b A. J$g(Abraham J.)$0868908 701 2$aJain$b Jay Prakash$0868909 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910139455003321 996 $aBiodegradable polymers in clinical use and clinical development$91939804 997 $aUNINA LEADER 02008oas 2200781 a 450 001 9910147027503321 005 20251114213013.0 011 $a1878-5948 035 $a(DE-599)ZDB2016274-1 035 $a(DE-599)2016274-1 035 $a(OCoLC)38492330 035 $a(CONSER) 2005233375 035 $a(CKB)954926246555 035 $a(EXLCZ)99954926246555 100 $a19980223b19931998 sy 101 0 $aeng 135 $aurmnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAdvanced cement based materials 210 $a[New York] $cElsevier Science Pub. Co.$d1993-1998 300 $aRefereed/Peer-reviewed 300 $aTitle from contents screen (ScienceDirect, viewed October 17, 2005). 311 08$a1065-7355 517 1 $aACBM 531 1 $aAdv. cem. based mater. 606 $aCement$vPeriodicals 606 $aConcrete$vPeriodicals 606 $aCiment$xPe?riodiques 606 $aBe?ton$xPe?riodiques 606 $aCiment$vPe?riodiques 606 $aBe?ton$vPe?riodiques 606 $aCement$2fast$3(OCoLC)fst00850432 606 $aConcrete$2fast$3(OCoLC)fst00874126 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 615 0$aCement 615 0$aConcrete 615 6$aCiment$xPe?riodiques. 615 6$aBe?ton$xPe?riodiques. 615 6$aCiment 615 6$aBe?ton 615 7$aCement. 615 7$aConcrete. 712 02$aAmerican Concrete Institute 801 0$bOH1 801 1$bOH1 801 2$bOCL 801 2$bOCLCQ 801 2$bGUA 801 2$bU9S 801 2$bWAU 801 2$bOCLCQ 801 2$bOCLCF 801 2$bOCLCO 801 2$bVT2 801 2$bOCLCQ 801 2$bU3W 801 2$bBWN 801 2$bOCLCO 801 2$bOCLCQ 801 2$bOCLCL 801 2$bOCLCQ 906 $aJOURNAL 912 $a9910147027503321 996 $aAdvanced cement based materials$91897867 997 $aUNINA